Stranger than fiction.

Barron’s gets bullish on Disney, Abercrombie & Fitch and Marvell Technology.

Hallmark/Westland says cash is tight in the wake of the nation’s biggest beef recall.

Wharton professors weigh in on the potential impact of all of those $600 to $1,200 rebate checks.

The new breast cancer use will ratchet up both the stock and sales, while the biotech sector as a whole could see a boost.

The latest and dumbest out of the 2008 International Toy Fair, and more.

Cell Genesys’ ‘news’ this week doesn’t do much to boost prospects for its prostate cancer vaccine.

Here are some of the best and worst performers among gold funds in the past week.

These two giants favor bridge, so why do most traders play poker?

Economic data could get really ugly.